Symbols / AFIB $0.00 +100.00% Acutus Medical, Inc.
AFIB Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2022-08-16 | main | Goldman Sachs | — → Neutral | $2 |
| 2022-06-24 | main | BTIG | — → Buy | $2 |
| 2022-04-27 | up | BTIG | Neutral → Buy | $2 |
| 2022-04-14 | main | Goldman Sachs | — → Neutral | $1 |
| 2022-01-20 | down | BTIG | Buy → Neutral | — |
| 2022-01-14 | down | Canaccord Genuity | Buy → Hold | $3 |
| 2021-11-12 | down | JP Morgan | Neutral → Underweight | — |
| 2021-11-12 | main | Canaccord Genuity | — → Buy | $10 |
| 2021-10-22 | init | Goldman Sachs | — → Neutral | $10 |
| 2021-07-15 | up | Canaccord Genuity | Hold → Buy | $18 |
| 2021-03-19 | main | Canaccord Genuity | — → Hold | $16 |
| 2021-03-19 | down | William Blair | Outperform → Market Perform | — |
| 2021-03-19 | down | JP Morgan | Overweight → Neutral | $19 |
| 2021-01-14 | down | B of A Securities | Buy → Neutral | — |
| 2020-08-31 | init | William Blair | — → Outperform | — |
| 2020-08-31 | init | Canaccord Genuity | — → Hold | $30 |
| 2020-08-31 | init | B of A Securities | — → Buy | $38 |
| 2020-08-31 | init | JP Morgan | — → Overweight | $39 |
- Afib surgery innovator AtriCure to join Goldman Sachs health conference - Stock Titan Wed, 27 May 2026 12
- Can a Coffee a Day Keep AFib Away? - The American Journal of Managed Care® (AJMC®) hu, 13 Nov 2025 08
- EGRMC's Dr. Richard Petrella's study highlights the urgent need for better AFib prevention and treatment - Grice Connect Sat, 16 Aug 2025 07
- Coffee Lovers With Afib Have Good News: A Daily Cup May Lower Risk - Everyday Health Mon, 10 Nov 2025 08
- This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now? - webull.com.my ue, 23 Dec 2025 08
- AtriCure launches first-of-its-kind clinical trial to prevent post-operative atrial fibrillation - Medical Economics ue, 28 Oct 2025 07
- AFIB Stock Price and Chart — OTC:AFIB - TradingView Sun, 12 May 2024 01
- Smartwatches detect AFib with high diagnostic accuracy - TechTarget Fri, 21 Nov 2025 08
- Why Is Acutus Medical (AFIB) Stock Down 41% Today? - InvestorPlace Mon, 06 May 2024 07
- 4 new studies test Abbott devices for irregular heartbeats - Stock Titan Sat, 25 Apr 2026 07
- Acutus Medical Inc. (AFIB) reports earnings - qz.com Mon, 24 Mar 2025 07
- Advanced treatment options for atrial fibrillation at International Heart Institute - Loma Linda University Fri, 10 Jan 2025 08
- Acutus Medical Stock Price Forecast. Should You Buy AFIB? - StockInvest.us Sat, 12 Dec 2020 01
- What to know about fending off AFib - Center for Science in the Public Interest Mon, 30 Jun 2025 20
- First 7 patients get Pulse catheter in pivotal AFib trial - Stock Titan ue, 07 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
20.16
+181.37%
|
7.16
+136.36%
|
3.03
-82.44%
|
17.26
|
| Operating Revenue |
|
20.16
+181.37%
|
7.16
+136.36%
|
3.03
-82.44%
|
17.26
|
| Cost Of Revenue |
|
19.14
+85.85%
|
10.30
+108.48%
|
4.94
-84.99%
|
32.92
|
| Reconciled Cost Of Revenue |
|
19.14
+85.85%
|
10.30
+108.48%
|
4.94
-84.99%
|
32.92
|
| Gross Profit |
|
1.01
+132.29%
|
-3.14
-64.24%
|
-1.91
+87.80%
|
-15.66
|
| Operating Expense |
|
10.44
-40.53%
|
17.55
-25.11%
|
23.43
-76.62%
|
100.21
|
| Research And Development |
|
0.00
-100.00%
|
3.48
+11.67%
|
3.12
-91.50%
|
36.68
|
| Selling General And Administration |
|
10.44
-25.81%
|
14.07
-30.76%
|
20.32
-68.02%
|
63.52
|
| Total Expenses |
|
29.58
+6.22%
|
27.85
-1.85%
|
28.37
-78.69%
|
133.13
|
| Operating Income |
|
-9.42
+54.45%
|
-20.68
+18.38%
|
-25.34
+78.13%
|
-115.87
|
| Total Operating Income As Reported |
|
-0.06
+99.51%
|
-11.73
-128.57%
|
41.04
+136.61%
|
-112.12
|
| EBITDA |
|
2.25
+142.20%
|
-5.33
-115.14%
|
35.20
+133.49%
|
-105.12
|
| Normalized EBITDA |
|
-7.33
+57.43%
|
-17.22
+25.98%
|
-23.27
+78.63%
|
-108.86
|
| Reconciled Depreciation |
|
1.03
+17.51%
|
0.87
-27.65%
|
1.21
-82.47%
|
6.89
|
| EBIT |
|
1.22
+119.70%
|
-6.20
-118.25%
|
34.00
+130.35%
|
-112.01
|
| Total Unusual Items |
|
9.58
-19.45%
|
11.89
-79.66%
|
58.47
+1460.92%
|
3.75
|
| Total Unusual Items Excluding Goodwill |
|
9.58
-19.45%
|
11.89
-79.66%
|
58.47
+1460.92%
|
3.75
|
| Special Income Charges |
|
9.37
+4.57%
|
8.96
-84.67%
|
58.44
+1460.04%
|
3.75
|
| Other Special Charges |
|
—
|
—
|
7.95
|
—
|
| Impairment Of Capital Assets |
|
—
|
0.00
-100.00%
|
12.03
|
0.00
|
| Restructuring And Mergern Acquisition |
|
1.45
+1077.24%
|
0.12
-88.32%
|
1.05
+128.11%
|
-3.75
|
| Net Income |
|
-9.55
+88.31%
|
-81.66
-106.14%
|
-39.62
+66.34%
|
-117.68
|
| Pretax Income |
|
-4.54
+61.75%
|
-11.86
-141.11%
|
28.85
+124.51%
|
-117.68
|
| Net Non Operating Interest Income Expense |
|
-5.00
-62.86%
|
-3.07
+28.36%
|
-4.28
+23.02%
|
-5.56
|
| Interest Expense Non Operating |
|
5.76
+1.82%
|
5.66
+9.83%
|
5.15
-9.30%
|
5.68
|
| Net Interest Income |
|
-5.00
-62.86%
|
-3.07
+28.36%
|
-4.28
+23.02%
|
-5.56
|
| Interest Expense |
|
5.76
+1.82%
|
5.66
+9.83%
|
5.15
-9.30%
|
5.68
|
| Interest Income Non Operating |
|
0.76
-70.52%
|
2.59
+198.16%
|
0.87
+648.28%
|
0.12
|
| Interest Income |
|
0.76
-70.52%
|
2.59
+198.16%
|
0.87
+648.28%
|
0.12
|
| Other Income Expense |
|
9.88
-16.92%
|
11.89
-79.66%
|
58.47
+1460.92%
|
3.75
|
| Other Non Operating Income Expenses |
|
0.30
|
—
|
—
|
—
|
| Gain On Sale Of Security |
|
0.21
-92.68%
|
2.94
+8800.00%
|
0.03
|
—
|
| Gain On Sale Of Business |
|
10.81
+19.10%
|
9.08
-88.57%
|
79.47
|
0.00
|
| Tax Provision |
|
0.00
-100.00%
|
0.06
+320.00%
|
0.01
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+40284.62%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
-100.00%
|
2.50
+8115.31%
|
0.03
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-9.55
+88.31%
|
-81.66
-106.14%
|
-39.62
+66.34%
|
-117.68
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.54
+61.95%
|
-11.92
-141.34%
|
28.83
+124.50%
|
-117.68
|
| Net Income From Continuing And Discontinued Operation |
|
-9.55
+88.31%
|
-81.66
-106.14%
|
-39.62
+66.34%
|
-117.68
|
| Net Income Continuous Operations |
|
-4.54
+61.95%
|
-11.92
-141.34%
|
28.83
+124.50%
|
-117.68
|
| Net Income Discontinuous Operations |
|
-5.01
+92.81%
|
-69.74
-1.89%
|
-68.45
|
—
|
| Normalized Income |
|
-14.12
+33.78%
|
-21.32
+28.00%
|
-29.61
+75.62%
|
-121.43
|
| Net Income Common Stockholders |
|
-9.55
+88.31%
|
-81.66
-106.14%
|
-39.62
+66.34%
|
-117.68
|
| Diluted EPS |
|
—
|
-2.81
-100.71%
|
-1.40
+65.94%
|
-4.11
|
| Basic EPS |
|
—
|
-2.81
-100.71%
|
-1.40
+65.94%
|
-4.11
|
| Basic Average Shares |
|
—
|
29.10
+2.73%
|
28.32
-1.16%
|
28.65
|
| Diluted Average Shares |
|
—
|
29.10
+2.73%
|
28.32
-1.16%
|
28.65
|
| Diluted NI Availto Com Stockholders |
|
-9.55
+88.31%
|
-81.66
-106.14%
|
-39.62
+66.34%
|
-117.68
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
28.65
-46.91%
|
53.96
-59.56%
|
133.44
-21.41%
|
169.79
|
| Current Assets |
|
25.58
-44.70%
|
46.25
-60.76%
|
117.87
-6.67%
|
126.29
|
| Cash Cash Equivalents And Short Term Investments |
|
14.02
-37.42%
|
22.40
-68.20%
|
70.45
-30.09%
|
100.77
|
| Cash And Cash Equivalents |
|
14.02
-26.87%
|
19.17
-25.07%
|
25.58
+6.29%
|
24.07
|
| Other Short Term Investments |
|
0.00
-100.00%
|
3.23
-92.79%
|
44.86
-41.51%
|
76.70
|
| Receivables |
|
7.88
-30.61%
|
11.35
-49.81%
|
22.62
+522.68%
|
3.63
|
| Accounts Receivable |
|
7.88
-30.61%
|
11.35
-36.64%
|
17.92
+393.23%
|
3.63
|
| Other Receivables |
|
—
|
—
|
4.70
|
—
|
| Inventory |
|
1.79
-58.16%
|
4.28
+138.46%
|
1.79
-89.07%
|
16.41
|
| Raw Materials |
|
1.19
-65.40%
|
3.43
+290.43%
|
0.88
-87.05%
|
6.78
|
| Work In Process |
|
0.58
+82.76%
|
0.32
+61.93%
|
0.20
-88.88%
|
1.77
|
| Finished Goods |
|
0.02
-96.05%
|
0.53
-26.15%
|
0.72
-90.85%
|
7.86
|
| Prepaid Assets |
|
—
|
—
|
—
|
5.33
|
| Restricted Cash |
|
0.00
-100.00%
|
7.03
+21.96%
|
5.76
+3742.67%
|
0.15
|
| Assets Held For Sale Current |
|
1.25
+145.10%
|
0.51
-96.81%
|
15.99
|
—
|
| Other Current Assets |
|
0.64
-5.46%
|
0.68
-45.93%
|
1.25
-76.46%
|
5.33
|
| Total Non Current Assets |
|
3.07
-60.17%
|
7.71
-50.50%
|
15.57
-64.20%
|
43.50
|
| Net PPE |
|
2.98
-25.86%
|
4.01
-27.56%
|
5.54
-69.54%
|
18.19
|
| Gross PPE |
|
6.69
-12.39%
|
7.64
-14.15%
|
8.90
-70.43%
|
30.09
|
| Accumulated Depreciation |
|
-3.72
-2.54%
|
-3.62
-7.99%
|
-3.36
+71.80%
|
-11.90
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
3.24
-6.35%
|
3.46
-0.06%
|
3.46
-52.36%
|
7.27
|
| Construction In Progress |
|
0.04
+485.71%
|
0.01
-99.29%
|
0.98
+2.30%
|
0.96
|
| Other Properties |
|
2.46
-22.89%
|
3.19
-17.64%
|
3.87
-81.80%
|
21.28
|
| Leases |
|
0.95
-3.06%
|
0.98
+68.79%
|
0.58
-0.34%
|
0.58
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
1.58
-90.71%
|
17.04
|
| Goodwill |
|
—
|
—
|
0.00
-100.00%
|
12.03
|
| Other Intangible Assets |
|
—
|
—
|
1.58
-68.42%
|
5.01
|
| Investments And Advances |
|
—
|
—
|
0.00
-100.00%
|
7.12
|
| Other Non Current Assets |
|
0.09
-97.46%
|
3.69
-63.18%
|
10.03
+770.83%
|
1.15
|
| Total Liabilities Net Minority Interest |
|
40.24
-26.62%
|
54.84
-6.13%
|
58.42
-8.81%
|
64.07
|
| Current Liabilities |
|
12.44
-34.34%
|
18.94
-4.68%
|
19.87
+7.36%
|
18.51
|
| Payables And Accrued Expenses |
|
3.30
-3.62%
|
3.42
+2.18%
|
3.35
-63.29%
|
9.13
|
| Payables |
|
1.28
-53.78%
|
2.76
+4.03%
|
2.65
-65.03%
|
7.59
|
| Accounts Payable |
|
1.28
-53.78%
|
2.76
+11.65%
|
2.47
-67.11%
|
7.52
|
| Current Accrued Expenses |
|
2.02
+205.59%
|
0.66
-4.89%
|
0.70
-54.69%
|
1.54
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.98
-55.82%
|
2.23
-8.55%
|
2.43
-65.67%
|
7.09
|
| Total Tax Payable |
|
—
|
0.00
-100.00%
|
0.18
+154.93%
|
0.07
|
| Current Debt And Capital Lease Obligation |
|
7.96
+208.37%
|
2.58
+709.40%
|
0.32
-19.24%
|
0.40
|
| Current Debt |
|
7.00
+275.80%
|
1.86
|
—
|
—
|
| Other Current Borrowings |
|
7.00
+275.80%
|
1.86
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.96
+33.29%
|
0.72
+125.08%
|
0.32
-19.24%
|
0.40
|
| Current Deferred Liabilities |
|
—
|
—
|
0.33
-18.70%
|
0.40
|
| Current Deferred Revenue |
|
—
|
—
|
0.33
-18.70%
|
0.40
|
| Other Current Liabilities |
|
0.19
-98.19%
|
10.71
-22.21%
|
13.77
+818.00%
|
1.50
|
| Total Non Current Liabilities Net Minority Interest |
|
27.80
-22.55%
|
35.90
-6.88%
|
38.55
-15.38%
|
45.56
|
| Long Term Debt And Capital Lease Obligation |
|
27.80
-22.55%
|
35.90
-6.85%
|
38.54
-14.37%
|
45.01
|
| Long Term Debt |
|
25.56
-21.71%
|
32.65
-5.17%
|
34.43
-14.80%
|
40.41
|
| Long Term Capital Lease Obligation |
|
2.24
-30.99%
|
3.24
-20.96%
|
4.10
-10.63%
|
4.59
|
| Other Non Current Liabilities |
|
—
|
—
|
0.01
-97.82%
|
0.55
|
| Stockholders Equity |
|
-11.59
-1218.77%
|
-0.88
-101.17%
|
75.02
-29.04%
|
105.73
|
| Common Stock Equity |
|
-11.59
-1218.77%
|
-0.88
-101.17%
|
75.02
-29.04%
|
105.73
|
| Capital Stock |
|
0.03
+3.45%
|
0.03
+0.00%
|
0.03
+3.57%
|
0.03
|
| Common Stock |
|
0.03
+3.45%
|
0.03
+0.00%
|
0.03
+3.57%
|
0.03
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
29.91
+2.04%
|
29.31
+2.66%
|
28.55
+2.14%
|
27.96
|
| Ordinary Shares Number |
|
29.91
+2.04%
|
29.31
+2.66%
|
28.55
+2.14%
|
27.96
|
| Additional Paid In Capital |
|
598.67
-0.21%
|
599.93
+0.97%
|
594.17
+1.64%
|
584.61
|
| Retained Earnings |
|
-609.52
-1.59%
|
-599.98
-15.76%
|
-518.31
-8.28%
|
-478.70
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.77
+11.32%
|
-0.87
+0.35%
|
-0.87
-300.46%
|
-0.22
|
| Other Equity Adjustments |
|
-0.77
+11.32%
|
-0.87
+0.35%
|
-0.87
-300.46%
|
-0.22
|
| Total Equity Gross Minority Interest |
|
-11.59
-1218.77%
|
-0.88
-101.17%
|
75.02
-29.04%
|
105.73
|
| Total Capitalization |
|
13.97
-56.03%
|
31.77
-70.97%
|
109.45
-25.10%
|
146.14
|
| Working Capital |
|
13.14
-51.89%
|
27.31
-72.13%
|
98.00
-9.08%
|
107.78
|
| Invested Capital |
|
20.98
-37.64%
|
33.64
-69.27%
|
109.45
-25.10%
|
146.14
|
| Total Debt |
|
35.76
-7.06%
|
38.48
-0.97%
|
38.86
-14.42%
|
45.40
|
| Net Debt |
|
18.55
+20.86%
|
15.35
+73.42%
|
8.85
-45.85%
|
16.34
|
| Capital Lease Obligations |
|
3.19
-19.34%
|
3.96
-10.43%
|
4.42
-11.31%
|
4.99
|
| Net Tangible Assets |
|
-11.59
-1218.77%
|
-0.88
-101.17%
|
75.02
-15.41%
|
88.69
|
| Tangible Book Value |
|
-11.59
-1218.77%
|
-0.88
-101.17%
|
75.02
-15.41%
|
88.69
|
| Available For Sale Securities |
|
—
|
—
|
—
|
7.12
|
| Investmentin Financial Assets |
|
—
|
—
|
0.00
-100.00%
|
7.12
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-31.66
+49.84%
|
-63.12
+29.01%
|
-88.92
+10.80%
|
-99.68
|
| Cash Flow From Continuing Operating Activities |
|
-17.18
+13.43%
|
-19.85
+35.65%
|
-30.85
+69.06%
|
-99.68
|
| Cash From Discontinued Operating Activities |
|
-14.47
+66.55%
|
-43.27
+25.49%
|
-58.07
|
—
|
| Net Income From Continuing Operations |
|
-4.54
+61.95%
|
-11.92
+69.91%
|
-39.62
+66.34%
|
-117.68
|
| Depreciation Amortization Depletion |
|
1.03
+17.51%
|
0.87
-27.65%
|
1.21
-82.47%
|
6.89
|
| Depreciation |
|
1.03
+17.51%
|
0.87
-11.54%
|
0.99
-84.19%
|
6.25
|
| Amortization Cash Flow |
|
—
|
0.00
-100.00%
|
0.22
-65.63%
|
0.64
|
| Depreciation And Amortization |
|
1.03
+17.51%
|
0.87
-27.65%
|
1.21
-82.47%
|
6.89
|
| Amortization Of Intangibles |
|
—
|
0.00
-100.00%
|
0.22
-65.63%
|
0.64
|
| Other Non Cash Items |
|
0.93
+34.15%
|
0.69
-98.95%
|
66.33
+41553.13%
|
-0.16
|
| Stock Based Compensation |
|
0.46
-84.86%
|
3.03
-10.82%
|
3.40
-75.28%
|
13.75
|
| Asset Impairment Charge |
|
—
|
0.00
-100.00%
|
12.03
|
0.00
|
| Operating Gains Losses |
|
-11.03
+8.22%
|
-12.02
+83.20%
|
-71.55
-255639.29%
|
0.03
|
| Gain Loss On Investment Securities |
|
-0.21
+92.68%
|
-2.94
-8800.00%
|
-0.03
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
|
0.00
-100.00%
|
0.03
|
| Change In Working Capital |
|
-4.01
-537.66%
|
0.92
+135.04%
|
-2.61
+30.99%
|
-3.79
|
| Change In Receivables |
|
-4.05
-211.55%
|
3.63
+170.23%
|
-5.17
-250.78%
|
-1.47
|
| Changes In Account Receivables |
|
-4.05
-276.91%
|
-1.07
-131.47%
|
-0.46
+68.50%
|
-1.47
|
| Change In Inventory |
|
2.49
+200.16%
|
-2.48
-3721.54%
|
-0.07
+98.32%
|
-3.87
|
| Change In Prepaid Assets |
|
0.05
-92.68%
|
0.66
-73.25%
|
2.45
+116.42%
|
1.13
|
| Change In Payables And Accrued Expense |
|
-1.73
-320.15%
|
-0.41
-133.50%
|
1.23
+81.42%
|
0.68
|
| Change In Accrued Expense |
|
-0.25
+64.86%
|
-0.70
-148.81%
|
1.43
-7.42%
|
1.55
|
| Change In Payable |
|
-1.49
-615.63%
|
0.29
+241.18%
|
-0.20
+76.58%
|
-0.87
|
| Change In Account Payable |
|
-1.49
-615.63%
|
0.29
+241.18%
|
-0.20
+76.58%
|
-0.87
|
| Change In Other Current Assets |
|
—
|
0.00
|
0.00
-100.00%
|
0.30
|
| Change In Other Current Liabilities |
|
-0.77
-61.95%
|
-0.47
+55.55%
|
-1.06
-90.68%
|
-0.56
|
| Investing Cash Flow |
|
22.15
-62.17%
|
58.55
-44.10%
|
104.75
+449.41%
|
19.07
|
| Cash Flow From Continuing Investing Activities |
|
21.81
-63.51%
|
59.77
-44.92%
|
108.50
+469.10%
|
19.07
|
| Cash From Discontinued Investing Activities |
|
0.34
+127.99%
|
-1.21
+67.74%
|
-3.75
|
—
|
| Net PPE Purchase And Sale |
|
-0.11
+48.86%
|
-0.22
+3.95%
|
-0.23
+97.71%
|
-9.97
|
| Purchase Of PPE |
|
-0.11
+48.86%
|
-0.22
+3.95%
|
-0.23
+97.71%
|
-9.97
|
| Capital Expenditure |
|
-0.11
+48.86%
|
-0.22
+3.95%
|
-0.23
+97.71%
|
-9.97
|
| Net Investment Purchase And Sale |
|
3.25
-92.44%
|
42.98
+10.98%
|
38.73
+33.38%
|
29.04
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-39.77
+27.05%
|
-54.51
+37.53%
|
-87.26
|
| Sale Of Investment |
|
3.25
-96.07%
|
82.75
-11.25%
|
93.24
-19.83%
|
116.30
|
| Net Business Purchase And Sale |
|
18.67
+9.84%
|
17.00
-75.71%
|
70.00
|
0.00
|
| Gain Loss On Sale Of Business |
|
-10.81
-19.10%
|
-9.08
+88.57%
|
-79.47
|
0.00
|
| Financing Cash Flow |
|
-2.89
-8.52%
|
-2.66
+77.07%
|
-11.62
-114.60%
|
79.57
|
| Cash Flow From Continuing Financing Activities |
|
-2.85
-19.55%
|
-2.38
+79.48%
|
-11.62
-114.60%
|
79.57
|
| Net Issuance Payments Of Debt |
|
-2.62
|
0.00
+100.00%
|
-9.72
|
0.00
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
34.83
|
0.00
|
| Repayment Of Debt |
|
-2.62
|
0.00
+100.00%
|
-44.55
|
0.00
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
34.83
|
0.00
|
| Long Term Debt Payments |
|
-2.62
|
0.00
+100.00%
|
-44.55
|
0.00
|
| Net Long Term Debt Issuance |
|
-2.62
|
0.00
+100.00%
|
-9.72
|
0.00
|
| Net Common Stock Issuance |
|
—
|
0.00
+100.00%
|
-0.11
-100.13%
|
82.66
|
| Common Stock Payments |
|
—
|
0.00
+100.00%
|
-0.11
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-0.11
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.03
-89.68%
|
0.28
-75.59%
|
1.15
|
| Net Other Financing Charges |
|
-0.23
+90.68%
|
-2.41
-17.08%
|
-2.06
+51.38%
|
-4.24
|
| Changes In Cash |
|
-12.40
-71.61%
|
-7.23
-271.34%
|
4.22
+502.87%
|
-1.05
|
| Effect Of Exchange Rate Changes |
|
0.22
-89.37%
|
2.08
-28.53%
|
2.91
+2607.76%
|
-0.12
|
| Beginning Cash Position |
|
26.20
-16.42%
|
31.35
+29.42%
|
24.22
-4.58%
|
25.38
|
| End Cash Position |
|
14.02
-46.49%
|
26.20
-16.42%
|
31.35
+29.42%
|
24.22
|
| Free Cash Flow |
|
-31.77
+49.84%
|
-63.34
+28.95%
|
-89.14
+18.70%
|
-109.66
|
| Interest Paid Supplemental Data |
|
4.54
-9.34%
|
5.01
+18.46%
|
4.23
-0.66%
|
4.26
|
| Amortization Of Securities |
|
-0.03
+98.04%
|
-1.43
-5850.00%
|
-0.02
-101.88%
|
1.28
|
| Common Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
82.66
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
-100.00%
|
82.66
|
| Sale Of Business |
|
18.67
+9.84%
|
17.00
-75.71%
|
70.00
|
0.00
|
| Cash From Discontinued Financing Activities |
|
-0.04
+85.36%
|
-0.28
|
0.00
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|